| Symbol | VYCO |
|---|---|
| Name | VYCOR MEDICAL, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 33487 United States FL 951 Broken Sound Parkway Suite 320 |
| Telephone | (561) 558-2020 |
| Fax | — |
| — | |
| Website | http://www.vycormedical.com |
| Incorporation | US |
| Incorporated On | 2005 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Prager Metis CPAs LLC; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001424768 |
| Description | Vycor is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA cleared or registered medical solutions that are changing and improving lives every day. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Additional info from OTC: |
(30% Negative) Vycor Medical, Inc. (VYCO) Reports Q4 2025 Financial Results
Read more(30% Negative) Vycor Medical, Inc. (VYCO) Reports Q3 2025 Financial Results
Read more(66% Neutral) VYCOR MEDICAL, INC. (VYCO) Reports 64% Loss Reduction for 2025-06-30
Read more(30% Negative) Vycor Medical, Inc. (VYCO) Reports Q2 2025 Financial Results
Read more(30% Negative) Vycor Medical, Inc. (VYCO) Reports Q2 2025 Financial Results
Read moreNew Form 10-K - VYCOR MEDICAL INC Filed: 2025-04-15 AccNo: 0001641172-25-004744 Size: 5 MB
Read moreNew Form NT 10-K - VYCOR MEDICAL INC Filed: 2025-03-31 AccNo: 0001641172-25-001714 Size: 30 KB
Read more(42% Neutral) VYCOR MEDICAL, INC. (VYCO) Reports 530% Loss Increase for 2024-09-30
Read more